SL
Beats & Topics
Published In
Recent Article
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial
Upgrade for article links
2 total articles published
·
Editor
Get full access
Unlock verified emails, phone numbers, article links, and CSV exports.
Upgrade to Pro